1. Home
  2. BBNX vs RGR Comparison

BBNX vs RGR Comparison

Compare BBNX & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

N/A

Current Price

$10.94

Market Cap

493.1M

Sector

Health Care

ML Signal

N/A

Logo Sturm Ruger & Company Inc.

RGR

Sturm Ruger & Company Inc.

N/A

Current Price

$38.84

Market Cap

521.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BBNX
RGR
Founded
2015
1949
Country
United States
United States
Employees
423
N/A
Industry
Medical/Dental Instruments
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
493.1M
521.9M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
BBNX
RGR
Price
$10.94
$38.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
1
Target Price
$26.22
$43.00
AVG Volume (30 Days)
1.2M
132.2K
Earning Date
01-01-0001
06-02-2026
Dividend Yield
N/A
1.19%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$546,057,000.00
Revenue This Year
$34.99
$1.05
Revenue Next Year
$34.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.94
52 Week Low
$8.89
$28.33
52 Week High
$32.71
$48.21

Technical Indicators

Market Signals
Indicator
BBNX
RGR
Relative Strength Index (RSI) 25.81 59.37
Support Level N/A $35.41
Resistance Level $15.53 $47.86
Average True Range (ATR) 0.70 1.36
MACD 0.11 0.06
Stochastic Oscillator 20.75 82.56

Price Performance

Historical Comparison
BBNX
RGR

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

Share on Social Networks: